Skip to main content
Fig. 3 | Molecular Cancer

Fig. 3

From: Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer

Fig. 3

Immune Infiltration and Responsiveness to Immunotherapy across Clusters. A ESTIMATE scores and immune cell populations compared between Cluster 1 and Cluster 2. (B-E) TIDE analysis including TIDE score B Exclusion score C Dysfunction score D and potential immunotherapy responders E (*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001)

Back to article page

Molecular Cancer

ISSN: 1476-4598